Signal: Bruker continues acquisition spree with $108m PhenomeX purchase
US-based medical device manufacturer Bruker Corp (Bruker) announced last week (18 August) that it would acquire PhenomeX, a specialty cellular analysis company. Bruker has been busy over the last year, with GlobalData research suggesting that it has announced 23 deals since the start of 2022, many of which are merger and acquisition (M&A) related.

Read more on:
https://www.medicaldevice-network.com/news/bruker-continues-acquisition-spree-pheonomex/